4-113902542-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_024590.4(ARSJ):​c.1532G>A​(p.Arg511Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,613,970 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00084 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 2 hom. )

Consequence

ARSJ
NM_024590.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.641
Variant links:
Genes affected
ARSJ (HGNC:26286): (arylsulfatase family member J) Sulfatases (EC 3.1.5.6), such as ARSJ, hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules (Sardiello et al., 2005 [PubMed 16174644]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01693967).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ARSJNM_024590.4 linkuse as main transcriptc.1532G>A p.Arg511Lys missense_variant 2/2 ENST00000315366.8 NP_078866.3 Q5FYB0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ARSJENST00000315366.8 linkuse as main transcriptc.1532G>A p.Arg511Lys missense_variant 2/21 NM_024590.4 ENSP00000320219.7 Q5FYB0
ARSJENST00000509829.1 linkuse as main transcriptn.*1211G>A non_coding_transcript_exon_variant 4/41 ENSP00000421327.1 D6RGC1
ARSJENST00000509829.1 linkuse as main transcriptn.*1211G>A 3_prime_UTR_variant 4/41 ENSP00000421327.1 D6RGC1

Frequencies

GnomAD3 genomes
AF:
0.000835
AC:
127
AN:
152080
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00147
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000781
AC:
195
AN:
249550
Hom.:
1
AF XY:
0.000820
AC XY:
111
AN XY:
135394
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000557
Gnomad NFE exome
AF:
0.00139
Gnomad OTH exome
AF:
0.000825
GnomAD4 exome
AF:
0.00130
AC:
1894
AN:
1461890
Hom.:
2
Cov.:
32
AF XY:
0.00127
AC XY:
924
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.000388
Gnomad4 AMR exome
AF:
0.000268
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000412
Gnomad4 NFE exome
AF:
0.00164
Gnomad4 OTH exome
AF:
0.000447
GnomAD4 genome
AF:
0.000835
AC:
127
AN:
152080
Hom.:
0
Cov.:
32
AF XY:
0.000781
AC XY:
58
AN XY:
74272
show subpopulations
Gnomad4 AFR
AF:
0.000435
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000661
Gnomad4 NFE
AF:
0.00147
Gnomad4 OTH
AF:
0.000479
Alfa
AF:
0.00149
Hom.:
1
Bravo
AF:
0.000858
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000783
AC:
3
ESP6500EA
AF:
0.00182
AC:
15
ExAC
AF:
0.000637
AC:
77
EpiCase
AF:
0.00153
EpiControl
AF:
0.000948

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 20, 2021The c.1532G>A (p.R511K) alteration is located in exon 2 (coding exon 2) of the ARSJ gene. This alteration results from a G to A substitution at nucleotide position 1532, causing the arginine (R) at amino acid position 511 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
17
DANN
Benign
0.94
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.017
T
MetaSVM
Uncertain
-0.23
T
MutationAssessor
Benign
-0.13
N
PrimateAI
Benign
0.42
T
PROVEAN
Benign
0.55
N
REVEL
Benign
0.26
Sift
Benign
0.82
T
Sift4G
Benign
0.69
T
Polyphen
0.0
B
Vest4
0.086
MVP
0.87
MPC
0.34
ClinPred
0.0038
T
GERP RS
4.6
Varity_R
0.071
gMVP
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201324549; hg19: chr4-114823698; COSMIC: COSV59538992; COSMIC: COSV59538992; API